NorthView Acquisition Corp. Files 8-K/A Amendment

Ticker: NVACW · Form: 8-K/A · Filed: Oct 4, 2024 · CIK: 1859807

Northview Acquisition CORP 8-K/A Filing Summary
FieldDetail
CompanyNorthview Acquisition CORP (NVACW)
Form Type8-K/A
Filed DateOct 4, 2024
Risk Levelmedium
Pages4
Reading Time5 min
Key Dollar Amounts$0.0001, $11.50
Sentimentneutral

Sentiment: neutral

Topics: amendment, delisting-notice, listing-standards

TL;DR

NVAC filed an 8-K/A amendment, potentially signaling listing rule issues.

AI Summary

NorthView Acquisition Corp. filed an amendment (8-K/A) on October 4, 2024, to its Form 8-K originally reported on September 12, 2024. This amendment pertains to a notice of delisting or failure to meet continued listing standards and includes financial statements and exhibits. The filing date for the amendment is October 4, 2024.

Why It Matters

This filing indicates potential issues with NorthView Acquisition Corp.'s listing status on an exchange, which could impact its stock trading and investor confidence.

Risk Assessment

Risk Level: medium — Amendments to Form 8-K, especially those related to delisting notices, can signal significant financial or operational challenges for a company.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K/A filing?

This 8-K/A filing serves as an amendment to a previous Form 8-K, specifically addressing a notice of delisting or failure to satisfy continued listing rules, and includes financial statements and exhibits.

When was the original event reported that this amendment relates to?

The earliest event reported that this amendment relates to was on September 12, 2024.

What is the filing date of this amendment?

This amendment was filed on October 4, 2024.

What is the company's Central Index Key (CIK)?

The company's Central Index Key (CIK) is 0001859807.

What is the SIC code for NorthView Acquisition Corp.?

The Standard Industrial Classification (SIC) code for NorthView Acquisition Corp. is 3841, which corresponds to Surgical & Medical Instruments & Apparatus.

Filing Stats: 1,208 words · 5 min read · ~4 pages · Grade level 12.6 · Accepted 2024-10-04 16:30:33

Key Financial Figures

Filing Documents

01. Notice of Delisting or Failure to Satisfy a Continued

Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. As previously disclosed, on June 3, 2024, the Company received a delinquency notification letter from the Staff due to the Company's non-compliance with Nasdaq Listing Rule 5250(c)(1) (the "Listing Rule") as a result of the Company's failure to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2024. On September 12, 2024, the Company received a letter (the "Nasdaq Notice") from the Staff indicating the Company's non-compliance with the Listing Rule as a result of the Company's failure to timely file its Quarterly Report on Form 10-Q for the period ended June 30, 2024. This Nasdaq Notice has no immediate effect on the listing of the Company's securities on Nasdaq. However, if the Company fails to timely regain compliance with the Rule, the Company's securities will be subject to delisting from Nasdaq. The Nasdaq Notice also notified the Company that the Staff had determined to grant the Company an exception to enable it to regain compliance with the Listing Rule. Pursuant to the terms of the exception, the Company must file the following on or prior to October 14, 2024: The Company's Quarterly Report on Form 10-Q for the period ended March 31, 2024; and The Company's Quarterly Report on Form 10-Q for the period ended June 30, 2024. If the Company does not satisfy the terms of the exception, the Staff will provide written notification that the Company's securities will be delisted. At such time, the Company could appeal the Staff's determination to a Hearings Panel. The Company is working diligently to complete the Quarterly Reports noted above and expects to file the reports on or prior to the October 14, 2024 deadline. As required under Nasdaq Listing Rule 5810(b), the Company issued a press release on September [13], 2024, announcing that it had received the Nasdaq Notice. A copy of this press release is attached as

Forward-Looking Statements

Forward-Looking Statements This Form 8-K contains forward-looking statements, including statements about the financial condition, results of operations, earnings outlook and prospects of the Company. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. Forward-looking statements are typically identified by words such as "plan," "believe," "expect," "anticipate," "intend," "outlook," "estimate," "forecast," "project," "continue," "could," "may," "might," "possible," "potential," "predict," "should," "would" and other similar words and expressions, but the absence of these words does not mean that a statement is not forward-looking. The forward-looking statements are based on the current expectations of the Company's management and are inherently subject to uncertainties and changes in circumstances and their potential effects and speak only as of the date of such statement. There can be no assurance that future developments will be those that have been anticipated. These forward-looking statements involve a number of risks, uncertainties or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These factors include, without limitation, our ability to respond in a timely and satisfactory matter to the inquiries by Nasdaq, our ability to regain compliance with the Listing Rule and our ability to become current with our reports with the SEC. For additional information about factors that could cause actual results to differ materially from those described in the forward-looking are inherently uncertain. Except to the extent required by applicable law, we do not undertake any obligation to update o

01. Financial

Item 9.01. Financial (c) Exhibits: Exhibit No. Description 99.1 Press Release dated September 13, 2024 104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) 2 SIGNATURE Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NORTHVIEW ACQUISITION CORP. Dated: October 4, 2024 By: /s/ Fred Knechtel Name: Fred Knechtel Title: Chief Financial Officer 3

View Full Filing

View this 8-K/A filing on SEC EDGAR

View on Read The Filing